Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71610-374

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71610-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 20-12.5 mg (71610 0374 80)

The label for Lisinopril and Hydrochlorothiazide USP tablets shows a strength of 20 mg Lisinopril and 12.5 mg Hydrochlorothiazide per tablet. The container holds 180 tablets for oral use. The label includes storage instructions, dispensing requirements, and the labeler Aphena Pharma Solutions - Tennessee, LLC, with manufacturing by Invagen Pharmaceuticals Inc. in Cookeville, TN. The product is prescription only (RX Only).*

FDA Label Image

Bottle Label 10-12.5 mg (71610 0382 30)

Lisinopril and Hydrochlorothiazide Tablets label showing 10 mg/12.5 mg strength with a quantity of 30 tablets. The label includes storage instructions, manufacturer Aphena Pharma Solutions - Tennessee, LLC, and the product is indicated for oral use and prescription only.*

FDA Label Image

Bottle Label 20-25 mg (71610 0383 60)

Lisinopril and Hydrochlorothiazide USP 20 mg/25 mg tablets label showing a 90-tablet count bottle. The label includes storage instructions to store between 20-25°C, dispensing instructions, manufacturer information for Ivaxen Pharmaceuticals Inc. in Hauppauge, NY, and labeler Aphena Pharma Solutions in Cookeville, TN. The label notes this is an Rx only product.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structural Formula 1 (Image 01)

Chemical structure of Lisinopril, one of the active ingredients in Lisinopril and Hydrochlorothiazide tablets. The structure shows its distinctive molecular arrangement including a phenyl group and various functional groups characteristic of the compound.*

FDA Label Image

Structural Formula 2 (Image 02)

Chemical structure diagram showing a chlorinated benzene ring with sulfonamide groups and an attached imidazoline ring, representing the active ingredient hydrochlorothiazide in Lisinopril and Hydrochlorothiazide tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.